Twitter | Search | |
Acceleron Pharma
Clinical stage biopharma focused on engaging the body's ability to rebuild and repair its own cells and tissues. Review our guidelines:
287
Tweets
134
Following
936
Followers
Tweets
Acceleron Pharma Apr 15
Are you in the Boston area today? If so, come out and route on Team Momentum at the . is a proud supporter of this incredible team & their desire to help fund research for muscular dystrophy, provide care and empower families
Reply Retweet Like
Acceleron Pharma Apr 9
Did you know: 20% of people with FSHD require the use of a wheelchair at least some of the time? is studying a potentially pioneering therapy designed to increase muscle strength and function in patients w/ this debilitating neuromuscular disease
Reply Retweet Like
Acceleron Pharma Apr 5
and announce submission of a Biologics License Application to U.S. FDA for an investigational agent to treat &
Reply Retweet Like
Acceleron Pharma Apr 2
is committed to developing a therapy for the thousands of patients who suffer from serious blood disorders causing chronic anemia. Helpful resources here:
Reply Retweet Like
Acceleron Pharma Mar 26
Did you know: not only affects one’s ability to walk, but can also affect breathing? Visit Resource Center to learn more:
Reply Retweet Like
Acceleron Pharma Mar 19
Our mission is to transform the lives of patients with serious and rare diseases, with a focus in three important therapeutic areas
Reply Retweet Like
Acceleron Pharma Mar 11
will be presenting today at the Cowen & Co. 39th Annual Healthcare Conference at 1:30 p.m. ET. For more information, click here:
Reply Retweet Like
Acceleron Pharma Mar 5
We're pleased to announce that our investigational agent, ACE-083, has received Orphan Drug Designation from the FDA for Charcot-Marie-Tooth disease
Reply Retweet Like
Acceleron Pharma Mar 1
We asked employees to at yesterday’s event. We’re proud to support this important day and encourage everyone to take a minute to learn more about rare diseases
Reply Retweet Like
Acceleron Pharma Feb 28
Today is ! is dedicated to the development of life-changing medicines for patients with a range of serious & rare diseases. To learn more, click here: and remember to today!
Reply Retweet Like
Acceleron Pharma Feb 28
will be presenting today at the SVB Leerink 8th Annual Global Healthcare Conference at 3:00 p.m. EST. For more information, click here:
Reply Retweet Like
Acceleron Pharma Feb 27
reports Q4/FY 2018 financial and operational results today. Tune into the live webcast at 5 pm EST:
Reply Retweet Like
Acceleron Pharma Feb 19
Join us 2/27 @ 5pm EST to discuss Q4/FY 2018 financial results. More info here:
Reply Retweet Like
Acceleron Pharma Feb 13
Mark your calendar! will be participating in two upcoming investor conferences. Click here for more info:
Reply Retweet Like
Acceleron Pharma Feb 5
Every day, employees bring to work diverse experience and a passion for developing innovative therapies for patients. Scroll down to the bottom of our homepage and watch the Who We Are video:
Reply Retweet Like
Acceleron Pharma Jan 29
The effects of chronic extend far beyond fatigue and can take a heavy toll on patients and their families
Reply Retweet Like
Acceleron Pharma Jan 24
January is National Blood Donor Month and would like to thank all blood donors for their lifesaving contributions. Please roll up your sleeves and give
Reply Retweet Like
Acceleron Pharma Jan 10
Thank you for joining us at . If you missed our presentation this past Monday, you can watch a replay of it here:
Reply Retweet Like
Acceleron Pharma Jan 10
We are pleased to announce that has published results from a Phase 2 study of an investigational agent in patients with both RBC transfusion-dependent and non-transfusion-dependent
Reply Retweet Like
Acceleron Pharma Jan 7
Live from , catch our presentation today at 2pm PT. More info on the webcast here:
Reply Retweet Like